Natera has delivered a very large 3 year share price gain, and that surge now puts a spotlight on whether the current market value lines up with the cash flows the business is expected to generate.
Natera (NTRA) Stock May Be 33% Below Fair Value Despite FDA Breakthrough News
view original post